All Stories

  1. Reply to “No Clinical Association of Live Attenuated Influenza Vaccine with Nasal Carriage of Bacteria or Acute Otitis Media”: Specific Recommendations for Future Studies

    Article • mBio, May 2014, ASM Journals

    Michael Mina

  2. Estimating the prevalence of coinfection with influenza virus and the atypical bacteria Bordetella pertussis, Chlamydophila pneumoniae, and Mycoplasma pneumoniae

    Article • European Journal of Clinical Microbiology & Infectious Diseases, May 2014, Springer Science + Business Media

    Michael Mina

  3. Live Attenuated Influenza Vaccine Enhances Colonization of Streptococcus pneumoniae and Staphylococcus aureus in Mice

    Article • mBio, February 2014, ASM Journals

    Michael Mina

  4. Let technology do the work

    Article • Journal of Trauma and Acute Care Surgery, October 2013, Wolters Kluwer Health

    Michael Mina

  5. JAM-A associates with ZO-2, afadin, and PDZ-GEF1 to activate Rap2c and regulate epithelial barrier function

    Article • Molecular Biology of the Cell, July 2013, American Society for Cell Biology (ASCB)

    Michael Mina

  6. Live Attenuated Influenza Vaccine, But Not Pneumococcal Conjugate Vaccine, Protects Against Increased Density and Duration of Pneumococcal Carriage After Influenza Infection in Pneumococcal Colonized Mice

    Article • The Journal of Infectious Diseases, July 2013, Oxford University Press (OUP)

    Michael Mina